H. Kitschke

发表

[The value of tumor markers CA 15-3 and CEA in breast cancer].

C. Lindner, I. Buck, K. Böge, 1989, Archives of gynecology and obstetrics.

[Nonpuerperal mastitis--a disease with increasing clinical relevance?].

H. Kitschke, M. Bernauer, R. Koll, 1985, Geburtshilfe und Frauenheilkunde.

Occurrence of cyclopia, myelomeningocele, deafness, and abducens paralysis in siblings.

K. Held, H. Kitschke, U. Burck, 1982, American journal of medical genetics.

Congenital malformation syndromes and elevation of amniotic fluid α1‐fetoprotein

M. Carstensen, K. Held, H. Kitschke, 1981 .

[Cellular immunity in breast cancer patients].

M. Spielmann, H. Kitschke, K. Tietje, 1982, Onkologie.

Prophylaxis and treatment of bladder dysfunction after Wertheim-Meigs operation: the positive effect of early postoperative detrusor stimulation using the cholinergic drug betanecholchloride

M. Goetz, H. Kitschke, W. Heyl, 2007, International Urogynecology Journal.

Fenoterol depot and fenoterol in premature uterine contractions — a multicentric double-blind comparative study

W. Müller-Holve, H. Kitschke, D. Berg, 1987, Journal of Perinatal Medicine.

Congenital malformation syndromes and elevation of amniotic fluid alpha-fetoprotein.

M. Carstensen, K. Held, H. Kitschke, 1981, Teratology.